Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex

Fig. 1

Comparison of the scale scores on the Medical Outcomes Study 36-Item Short Form in patients with sirolimus gel treatment for facial angiofibroma with tuberous sclerosis complex before and after 3 months of treatment. PF, physical function; RP, role limitations because of physical health problems; BP, bodily pain; GH, general health perception; VT, vitality; SF, social function; RE, role limitations because of emotional problems; MH, mental health. *, P < 0.05. The scale scores of the VT, SF, and MH were significantly improved compared to before the treatment

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172